Kallidin
This article relies largely or entirely on a single source. (February 2017) |
Names | |
---|---|
IUPAC name
L-Lysyl-L-arginyl-L-prolyl-L-prolyl-glycyl-L-phenylalanyl-L-seryl-L-prolyl-L-phenylalanyl-L-arginine
| |
Identifiers | |
CAS Number
|
|
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.005.853 |
IUPHAR/BPS
|
|
MeSH | Kallidin |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
Chemical formula
|
C56H85N17O12 |
Molar mass | 1188.403 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
what is ?) | (|
Infobox references | |
Kallidin is a bioactive kinin formed in response to injury from kininogen precursors through the action of kallikreins.
Kallidin is a decapeptide whose sequence is H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH. It can be converted to bradykinin by the aminopeptidase enzyme.
It can be a substrate for carboxypeptidase M and N.[1]
Kallidin is identical to bradykinin with an additional lysine residue added at the N-terminal end and signals through the bradykinin receptor.
References[]
- ^ Stefan Offermanns; Walter Rosenthal (2008). Encyclopedia of Molecular Pharmacology. Springer. pp. 673–. ISBN 978-3-540-38916-3. Retrieved 11 December 2010.
Categories:
- Peptides
- Kinin–kallikrein system
- Biochemistry stubs